ReviewTargeted Therapeutics

Improving Treatment of HER2-Positive Cancers: Opportunities and Challenges

See allHide authors and affiliations

Science Translational Medicine  28 Mar 2012:
Vol. 4, Issue 127, pp. 127rv2
DOI: 10.1126/scitranslmed.3001539

Article Information

vol. 4 no. 127 127rv2

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication July 29, 2010
  • Accepted for publication January 3, 2012

Author Information

  1. Howard M. Stern
  1. Department of Research Pathology, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080–4990, USA. E-mail: stern.howard{at}gene.com

Altmetric

Article usage

Article usage: March 2012 to July 2019

AbstractFullPdf
Mar 20121948115200
Apr 20123159152350
May 201274266129
Jun 20123751347
Jul 20122841534
Aug 2012261934
Sep 20122591032
Oct 20123876960
Nov 20124154480
Dec 20123322353
Jan 20133013050
Feb 20132872637
Mar 20132761539
Apr 20132551537
May 20132631633
Jun 2013218926
Jul 20132251326
Aug 20131311922
Sep 20131651924
Oct 201338810464
Nov 20131561215
Dec 20131401022
Jan 20141881329
Feb 2014108920
Mar 2014137713
Apr 20141451219
May 201413559
Jun 20148379
Jul 201410947
Aug 201478312
Sep 20141773322
Oct 20142734242
Nov 201495514
Dec 2014109913
Jan 20151911924
Feb 2015781110
Mar 20156358
Apr 20159149
May 20156568
Jun 20156958
Jul 20153857
Aug 20153855
Sep 201541117
Oct 20152375636
Nov 201544118
Dec 201558517
Jan 2016751012
Feb 2016681111
Mar 20168948
Apr 201671720
May 201691311
Jun 20167087
Jul 2016821012
Aug 20166768
Sep 20166472
Oct 20162376737
Nov 201663313
Dec 20164462
Jan 20175564
Feb 20176696
Mar 20175033
Apr 20175326
May 201757184
Jun 20174194
Jul 201745138
Aug 20175268
Sep 201762117
Oct 20172457422
Nov 20175156
Dec 201745115
Jan 201839146
Feb 20182896
Mar 201853146
Apr 201864272
May 201867172
Jun 201867912
Jul 20184675
Aug 201826122
Sep 201832135
Oct 2018864939
Nov 2018563947
Dec 201857193
Jan 201941255
Feb 2019712511
Mar 2019422415
Apr 201927287
May 201933228
Jun 201943105
Jul 201916104